Trial
NCT00003508
Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Malignant Mesothelioma
Intervention
Antineoplaston therapy (Atengenal + Astugenal)
Why stopped
Withdrawn due to slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-27